About Nyxoah
Nyxoah is a company based in Mont-saint-guibert (Belgium) founded in 2009.. Nyxoah has raised $88.73 million across 10 funding rounds from investors including ResMed, Cochlear and European Union. The company has 11 employees as of December 31, 2020. Nyxoah offers products and services including Genio. Nyxoah operates in a competitive market with competitors including Muse, Biotricity, SleepScore Labs, Dreem and Jawbone, among others.
- Headquarter Mont-saint-guibert, Belgium
- Employees 11 as on 31 Dec, 2020
- Stage Public
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nyxoah Sa
-
Annual Revenue
$7.45 M (USD)27as on Dec 31, 2018
-
Net Profit
$10.51 M (USD)18as on Dec 31, 2018
-
EBITDA
-
Total Equity Funding
$88.73 M (USD)
in 10 rounds
-
Latest Funding Round
$26.4 M (USD), Post-IPO
Dec 18, 2025
-
Investors
ResMed
& 7 more
-
Employee Count
11
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nyxoah
Nyxoah offers a comprehensive portfolio of products and services, including Genio. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treats obstructive sleep apnea via hypoglossal nerve stimulation therapy.
Unlock access to complete
Unlock access to complete
Funding Insights of Nyxoah
Nyxoah has successfully raised a total of $88.73M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $26.4 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Post-IPO — $26.4M
-
First Round
First Round
(01 Jun 2009)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2025 | Amount | Post-IPO - Nyxoah | Valuation |
investors |
|
| Apr, 2023 | Amount | Post-IPO - Nyxoah | Valuation |
investors |
|
| Feb, 2020 | Amount | Series C - Nyxoah | Valuation | ResMed , Cochlear |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nyxoah
Nyxoah has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include ResMed, Cochlear and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Private equity and venture captial firm focused on healthcare sectors
|
Founded Year | Domain | Location | |
|
Buyouts are pursued by SRIW as a private equity firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nyxoah
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nyxoah
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nyxoah Comparisons
Competitors of Nyxoah
Nyxoah operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Muse, Biotricity, SleepScore Labs, Dreem and Jawbone, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
EEG-powered headbands for meditation and sleep biofeedback are developed.
|
|
| domain | founded_year | HQ Location |
Developer of medical remote monitoring solutions that help prevent and manage chronic diseases
|
|
| domain | founded_year | HQ Location |
Sleep quality is monitored via bedside devices and mobile apps.
|
|
| domain | founded_year | HQ Location |
Sleep quality is monitored via Dreem's wearable EEG device.
|
|
| domain | founded_year | HQ Location |
Provider of wearable devices for activity and sleep tracking
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nyxoah
Frequently Asked Questions about Nyxoah
When was Nyxoah founded?
Nyxoah was founded in 2009.
Where is Nyxoah located?
Nyxoah is headquartered in Mont-saint-guibert, Belgium.
Who is the current CEO of Nyxoah?
Olivier Taelman is the current CEO of Nyxoah.
Is Nyxoah a funded company?
Nyxoah is a funded company, having raised a total of $88.73M across 10 funding rounds to date. The company's 1st funding round was a Series C of $27.25M, raised on Jun 01, 2009.
How many employees does Nyxoah have?
As of Dec 31, 2020, the latest employee count at Nyxoah is 11.
What is the annual revenue of Nyxoah?
Annual revenue of Nyxoah is $7.45M as on Dec 31, 2018.
What does Nyxoah do?
Provider of a neurostimulation device for obstructive sleep apnea treatments. The companys product BLAST-OSA (BiLAteral Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnea) is used for treating sleep apnea and calculating ODI (Oxygen Desaturation Index) and AHI (Apnea-Hypopnea Index). Its system consists of an implant and disposable patch, which stimulate the nerves of the tongue to make it move, preventing airway obstruction.
Who are the top competitors of Nyxoah?
Nyxoah's top competitors include Muse, Jawbone and Biotricity.
What products or services does Nyxoah offer?
Nyxoah offers Genio.
Who are Nyxoah's investors?
Nyxoah has 8 investors. Key investors include ResMed, Cochlear, European Union, EIC Fund, and Gilde Healthcare.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.